Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group

Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pathol Transl Med
Autors principals: Chang, Sunhee, Shim, Hyo Sup, Kim, Tae Jung, Choi, Yoon-La, Kim, Wan Seop, Shin, Dong Hoon, Kim, Lucia, Park, Heae Surng, Lee, Geon Kook, Lee, Chang Hun
Format: Artigo
Idioma:Inglês
Publicat: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8141968/
https://ncbi.nlm.nih.gov/pubmed/33966368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2021.03.23
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars